|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | |
| A61K 31/4015 |
| (11) | Number of the document | 2358361 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09752825.1 |
| Date of filing the European patent application | 2009-11-17 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/065270 |
| Date | 2009-11-17 |
| (87) | Number | WO 2010/057869 |
| Date | 2010-05-27 |
| (30) | Number | Date | Country code |
| 08105817 | 2008-11-18 | EP | |
| 09100311 | 2009-06-02 | EP |
| (72) |
FANARA, Domenico, BE
EECKMAN, Frederic, BE
BERWAER, Monique, BE
|
| (73) |
UCB Biopharma SPRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | PROLONGED RELEASE FORMULATIONS COMPRISING AN 2-OXO-1-PYRROLIDINE DERIVATE |
| PROLONGED RELEASE FORMULATIONS COMPRISING AN 2-OXO-1-PYRROLIDINE DERIVATE |